Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

TTA-A2

Catalog No.
BA6572
Add to Compare
TTA-A2 is a potent, selective and orally active T-type voltage-gated calcium channel antagonist that reduces pregnane X receptor (PXR) activation.
Grouped product items
SizePriceStock Qty
1mL(10 mM in DMSO)
$376.00
Ship with 10-15 days
1mg
$162.00
Ship with 10-15 days
5mg
$342.00
Ship with 10-15 days
10mg
$531.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

TTA-A2 is a potent, selective, and orally active T-type voltage-gated calcium channel antagonist that reduces activation of the pregnane X receptor (PXR).TTA-A2 has the same effect on Cav3.1(aG) and Cav3.2(aH) channels at the -80mV and -100mV holding potentials, with values of 89nM and 92nM, respectively.TTA-A2 can be used in the a variety of human neurological disorders, including sleep disorders and epilepsy.

Chemical Properties

Physical AppearanceA solid
Storage-20°C
M.Wt378.39
Cas No.953778-63-7
FormulaC20H21F3N2O2
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.